首页 | 本学科首页   官方微博 | 高级检索  
检索        

转染Akt-1基因对大鼠心肌缺血-再灌注损伤的保护作用研究
引用本文:李东野,王静,夏勇,罗园媛,陈丹,潘德锋,朱红,宋建涛,徐通达.转染Akt-1基因对大鼠心肌缺血-再灌注损伤的保护作用研究[J].中国微循环,2009,13(6):469-474.
作者姓名:李东野  王静  夏勇  罗园媛  陈丹  潘德锋  朱红  宋建涛  徐通达
作者单位:1. 徐州医学院心血管病研究所,江苏徐州,221006
2. 南京军区南京总医院训练中心
3. 徐州医学院附属医院心内科
摘    要:目的通过观察转染Akt-1基因对大鼠心肌缺血-再灌注(I-R)损伤心脏功能及细胞凋亡相关蛋白的影响,探讨Akt-1基因对心肌I-R损伤保护作用的机制。方法使用结扎/松解左冠状动脉前降支法,结扎冠状动脉前降支30min,再灌注2h,建立大鼠在体心肌I-R模型。40只雄性SD大鼠随机分为五组:假手术组(S组),缺血-再灌注组(I—R组),转染Akt-1基因组(Gene组),空载体组(VC组),抑制剂组(AB组),每组8只。Gene组术前48h开胸心肌内直接分点注射脂质体Akt-1质粒复合物,S组和I-R组分别注射同等体积PBS,VC组注射等体积脂质体,AB组注射等体积脂质体Akt-1质粒LY294002混合物。所有大鼠经颈动脉插管至左心室记录HR、LVSP、LVEDP和±do/dtmax变化,TTC染色法测定心肌梗死范围,TUNEL法原位标记凋亡心肌细胞,Western Blot测定Akt-1、Casepase-3蛋白表达,免疫组化检测Bcl-2、Bax表达。结果1.Gene组较I—R组、VC组和AB组左室心功能(HR、LVSP、LVEDP、±dp/dtmax)改善(P〈0.05)。2.Gene组凋亡指数(AI)及心肌梗死范围较I-R组、VC组及AB组均显著减少(P〈0.05),但仍高于S组(P〈0.05);S组细胞凋亡阳性细胞几无表达,心肌细胞凋亡指数(AI)明显低于其余各组(P〈0.05)。3.各组均可见Akt-1、Casepase-3蛋白表达,但S组中蛋白较其余各组减少(P〈0.05);Gene组Akt-1蛋白表达较I-R组、VC组及AB组均增加(P〈0.05);Gene组Casepase-3蛋白表达则较I-R组、VC组及AB组减少。4.S组Bcl-2和Bax表达较其余各组减少(P〈0.05);Gene组较I-R组、VC组及AB组Bcl-2表达上调而Bax表达下调(P〈0.05)。结论Akt-1基因转染对I—R心肌具有保护作用,该作用可能与促进Bcl-2表达,抑制Bax和Casepase-3表达从而抑制凋亡的发生有关。

关 键 词:Akt-1  心肌再灌注损伤  基因  细胞凋亡

Study of the Protective Effects of Transgenic Akt-1 Gene After Cardiac Ischemia-reperfusion Injury in Rats
LI Dong-ye,WANG Jing,XIA Yong,LUO Yuan-yuan,CHEN Dan,PAN De-feng,ZHU Hong,SONG Jian-tao,XU Tong-da.Study of the Protective Effects of Transgenic Akt-1 Gene After Cardiac Ischemia-reperfusion Injury in Rats[J].Journal of Chinese Microcirculation,2009,13(6):469-474.
Authors:LI Dong-ye  WANG Jing  XIA Yong  LUO Yuan-yuan  CHEN Dan  PAN De-feng  ZHU Hong  SONG Jian-tao  XU Tong-da
Institution:LI Dong-ye, LUO Yuan-yuan, CHEN Dan, SONG Jian-tao, XIA Yong, PAN De-feng, ZHU Hong, XU Tong-da. Xuzhou (1 Cardiovascular Research Institute of Xuzhou Medical college, Cardiovascular Dept. of Xuzhou. WANG Jing. Training center of Nanfing General Hospital of Nanjing Military Command, China;2.Medical College Affiliated Hospital.)
Abstract:Objective To investigate the protective effects of transgenic Akt-1 gene on rats after ischemia-reperfusion injury in vivo. Methods 40 adult male SD rats were divided randomly into five groups with 8 rats in each group: sham operation group(S), ischemia/reperfusion group(I-R), Akt-1 gene group(Gene), Vechicle Control group(VC), Block group(AB). The rats in Gene group were injected 30μ1 Lipofectamine 2000 solution including Akt-1 gene to the myocardium 48 hours before ischemia while those in S group and I-R group were injected PBS of the same volume. In VC group, myocardium was injected Lipofectamine 2000 of the same volume. 30/xl Lipofectamine 2000 and gene complexes with LY29dO02 was injected in AB group. All rats were intubated to left ventricle and the changes of HR, LVSP, LVEDP, + dp/dtmax and -dp/dtmax were recorded.The apoptotic cells were assessed by TUNEL staining and apoptosis index (AI) was obtained, and the myocardial infarction area was evaluated by TIC dyeing. The changes of Bcl-2, Bax in myocardial cells were observed by immunohistochemistry. The expression of Akt-1 and Caspase-3 was determined by Western Blot . Results 1. The left ventricular function (LVF) of S group was higher than other groups (P 〈 0.05). LVF of I-R group, VC group and AB group were lower than Gene group (P 〈 0. 05). 2. Compared with those in S group, apoptosis index(AI) and myocardial infarction area increased significantly in other groups (P 〈0. 05). The M and myocardial infarction area in Gene group were significantly lower than those in I-R group, VC group and AB group (P 〈0.05 ). 3. In S group, the level of protein expression Akt-1 and Caspase-3 is the lowest, the protein expression of Akt-1 in Gene group is higher than I-R group, VC group and AB group, while the protein expression of Caspase-3 is on the contrary. 4. Compared with S group, the expression of Bcl-2 and Bax in other groups increased( P 〈 0. 05) ; the expression of Bcl-2 in Gene group is higher
Keywords:Akt-1
本文献已被 维普 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号